Stock recommendations for 2025: Motilal Oswal picks these 10 shares

Stock recommendations for 2025: Motilal Oswal picks these 10 shares

Kolkata: Prominent brokerage Motilal Oswal thinks the following stocks can provide significant returns in 2025. The brokerage firm in bullish about sectors such as healthcare, BFSI, IT, industrials, real estate. It is also enthusiastic on themes such as capital markets, EMS, digital ecommerce and hotels. The sectors are also substantially represented in the stock recommendations of Motilal Oswal for the next year.

Though FIIs (or Foreign Institutional Investors) have made major selloffs in the Indian stock markets in October and November that has brought down the net inflows of FIIs to about mere Rs 5,000 crore, some experts think that the situation may improve in 2025. None can guarantee what will happen to the markets next year. But for the moment, we can have a look at the following stocks since they have been recommended by one of the trusted names in the markets.

ICICI Bank, HCL Technologies

Motilal Oswal has assigned a ‘Buy’ on ICICI Bank. It has set target price at Rs 1,550, which is about 19.4% higher than current market price Rs 1,298.95. It has recorded 17% CAGR in loan of between FY22 and FY24. HCL Technologies’ company’s current market (CMP) price is Rs 1892.05. The target price is Rs 2,300 – 21.6% higher than the CMP. Motilal Oswal bullish about long term growth of IT major.

Larsen & Toubro, Zomato

Target price of Larsen & Toubro is Rs 4,300. It is 18.3% higher than the CMP of Rs 3,633. Brokerage thinks the aggressive expansion and growth in infrastructure gives it opportunity to grow. Zomato’s CMP is Rs 274.50 and the target price is Rs 330. This company has got big possibilities in the growing sector of delivery of food and grocery.

Nippon Life India AMC, Mankind Pharma

Against a CMP of Rs 753, the target price of Nippon Life has been set at Rs 900, which is 19.6% higher. Motilal Oswal assigned Buy signal to it, indicating strong presence in the market. Mankind Pharma’s target price has been set at Rs 3,140 crore. It is 8% higher than the CMP of Rs 2,909. This company has posted robust results for Q2 of FY25. It is doing very well in consumer and export divisions.

Lemon Tree Hotels, Polycab India

While the CMP of Lemon Tree Hotels is Rs 151.25, the target price has been set at Rs 190 (25.5% higher than). Lemon Tree Hotels has got a ‘Buy’ rating from the brokerage firm. Polycab India has a CMP of Rs 7,077, the target price is Rs 8,340 crore, which is 17.8% higher than current levels. The brokerage has given a “Buy’ rating to this one too.

Macrotech Developers, Syrma SGS Technology

The target price for Macrotech Developers, a real estate major, is Rs 1,770 – a good 26.7% higher than the CMP of Rs 1,397. The company’s growth even during the monsoon has ignited confidence of Motilal Oswal. The CMP of Syrma SGS Technology is Rs 599.50, while Motilal Oswal has assigned a target price of Rs 750 – as much as 25.2% higher than current levels. The robust order book of Rs 4,800 crore triggered confidence in the scrip.

 What are the stocks to pick in 2025? Prominent brokerage Motilal Oswal names ICICI Bank, HCL Technologies, Larsen & Toubro, Zomato, Nippon Life India AMC, Mankind Pharma, Lemon Tree Hotels, Polycab India, Macrotech Developers and Syrma SGS Technology  Markets Business News – Personal Finance News, Share Market News, BSE/NSE News, Stock Exchange News Today